Research

Hormonal

Systemically administered GABAA receptor agonistic modulators (barbiturates, benzodiazepines, zolpidem, zopiclone, neuroactive steroids) reduce sleep latency, increase NREM sleep continuity, and promote sleep spindles, but suppress slow-wave activity (SWA) and REM sleep.

GABAA-targeting sleep medications (like benzodiazepines or Z-drugs) generally help you fall asleep faster and stay asleep longer by increasing NREM sleep and spindles. However, they tend to reduce deep slow-wave sleep and REM sleep. If sleep quality (depth and dreaming) is your priority, these drugs may alter your sleep architecture in ways that feel less restorative despite longer duration.

GoodSupportsHIGH confidence
In both rats and normal sleeping individuals, agonistic modulators are able to reduce sleep latency, increase sleep continuity, and promote non-rapid-eye-movement (NREM) sleep as well as the occurrence of spindles. Furthermore, nearly all of these compounds have been shown to attenuate slow-wave activity (SWA) and to suppress the occurrence of REM sleep.
Marike Lancel · SLEEP · 1999

Why this rating

Based on a comprehensive review of multiple animal and human studies across various compounds.

Source

Role of GABAA Receptors in the Regulation of Sleep: Initial Sleep Responses to Peripherally Administered Modulators and Agonists

Marike Lancel · SLEEP · 1999

DOI 10.1093/sleep/22.1.33

narrative_reviewCited 236×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →